• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

血管内超声与光学相干断层扫描之间黑洞现象的最佳策略

The Best Strategy for the Black Hole Phenomenon between Intravascular Ultrasound and Optical Coherence Tomography.

作者信息

Kan Cheng-Cheng, Tsai Wei-Che, Cheng Cheng-Chung, Jong Gwo-Ping

机构信息

Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung 41152, Taiwan.

Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.

出版信息

Diagnostics (Basel). 2024 Jan 27;14(3):281. doi: 10.3390/diagnostics14030281.

DOI:10.3390/diagnostics14030281
PMID:38337797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10854961/
Abstract

The black hole (BH) phenomenon is an intraluminal restenotic lesion. It was identified by intravascular ultrasound (IVUS) and optical coherence tomography (OCT) after intracoronary brachytherapy and drug-eluting stent implantation. Despite the similarity in the mode of action of brachytherapy and drug-eluting stent implantation, the BH phenomenon appears to be uncommon after drug-eluting stent implantation. Specifically, the BH phenomenon is better identified by OCT than by IVUS. Herein, we present a case of in-stent restenosis with suspected BH phenomenon on IVUS and confirmed by OCT.

摘要

黑洞（BH）现象是一种管腔内再狭窄病变。它是在冠状动脉近距离放射治疗和药物洗脱支架植入术后通过血管内超声（IVUS）和光学相干断层扫描（OCT）识别出来的。尽管近距离放射治疗和药物洗脱支架植入术的作用方式相似，但BH现象在药物洗脱支架植入术后似乎并不常见。具体而言，OCT比IVUS更能清晰识别BH现象。在此，我们报告一例药物洗脱支架内再狭窄病例，IVUS怀疑存在BH现象，OCT予以确诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2c/10854961/a5e428a9183d/diagnostics-14-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2c/10854961/a262cea18e67/diagnostics-14-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2c/10854961/a5e428a9183d/diagnostics-14-00281-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2c/10854961/a262cea18e67/diagnostics-14-00281-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e2c/10854961/a5e428a9183d/diagnostics-14-00281-g002.jpg

相似文献

1
The Best Strategy for the Black Hole Phenomenon between Intravascular Ultrasound and Optical Coherence Tomography.血管内超声与光学相干断层扫描之间黑洞现象的最佳策略
Diagnostics (Basel). 2024 Jan 27;14(3):281. doi: 10.3390/diagnostics14030281.
2
Optical coherence tomography images of bell-shaped appearance in late sirolimus-eluting stent restenosis with extension of previous incomplete stent apposition.雷帕霉素洗脱支架晚期再狭窄伴先前不完全支架贴壁扩展时呈钟形外观的光学相干断层扫描图像。
J Cardiol Cases. 2011 Aug 27;4(3):e152-e155. doi: 10.1016/j.jccase.2011.08.001. eCollection 2011 Dec.
3
The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.与光学相干断层扫描相比，集成背向散射血管内超声在表征裸金属支架和药物洗脱支架再狭窄新生内膜中的作用。
J Cardiol. 2014 Dec;64(6):488-95. doi: 10.1016/j.jjcc.2014.03.007. Epub 2014 Apr 29.
4
Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation.药物洗脱支架植入术后“黑洞”现象的血管内超声特征
Am J Cardiol. 2006 Jan 15;97(2):203-6. doi: 10.1016/j.amjcard.2005.07.136. Epub 2005 Nov 28.
5
Qualitative assessment of neointimal tissue after drug-eluting stent implantation: comparison between follow-up optical coherence tomography and intravascular ultrasound.药物洗脱支架置入后新生内膜组织的定性评估：血管内超声与光学相干断层成像的随访比较。
Am Heart J. 2011 Feb;161(2):367-72. doi: 10.1016/j.ahj.2010.10.026.
6
Late in-stent restenosis after sirolimus-eluting stent implantation is related to thrombus formation-Insight from a case with IVUS, OCT, and histological findings.西罗莫司洗脱支架植入术后晚期支架内再狭窄与血栓形成相关——来自一例血管内超声、光学相干断层扫描及组织学结果病例的见解
J Cardiol Cases. 2012 Mar 17;5(2):e83-e86. doi: 10.1016/j.jccase.2011.11.004. eCollection 2012 Apr.
7
Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).光学相干断层成像指导支架扩张与血管内超声的比较：ILUMIEN II 研究（血流储备分数 [FFR] 和经皮冠状动脉介入治疗患者的光学相干断层成像 [OCT] 观察性研究）。
JACC Cardiovasc Interv. 2015 Nov;8(13):1704-14. doi: 10.1016/j.jcin.2015.07.024.
8
Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity.冠状动脉近距离放射治疗后的血管变化及黑洞现象：一种病理特征独特的实体。
J Invasive Cardiol. 2008 Oct;20(10):560-2.
9
Frequency and determinants of black holes in sirolimus-eluting stent restenosis.西罗莫司洗脱支架再狭窄中黑洞的发生率及决定因素
J Invasive Cardiol. 2006 Aug;18(8):348-52.
10
Use of intravascular ultrasound vs. optical coherence tomography for mechanism and patterns of in-stent restenosis among bare metal stents and drug eluting stents.血管内超声与光学相干断层扫描在裸金属支架和药物洗脱支架内支架再狭窄机制及模式中的应用比较
J Thorac Dis. 2016 Jan;8(1):E104-8. doi: 10.3978/j.issn.2072-1439.2016.01.48.

本文引用的文献

1
Evaluation and management of drug-eluting stent in-stent restenosis.药物洗脱支架内再狭窄的评估与处理。
Curr Opin Cardiol. 2023 Sep 1;38(5):433-440. doi: 10.1097/HCO.0000000000001073. Epub 2023 Jul 13.
2
Management of Restenosis after Stenting in Left Main Coronary Artery Disease.左主干冠状动脉疾病支架置入术后再狭窄的管理
Acta Cardiol Sin. 2023 Mar;39(2):277-286. doi: 10.6515/ACS.202303_39(2).20220821A.
3
Investigation Into the Risk Factors Related to In-stent Restenosis in Elderly Patients With Coronary Heart Disease and Type 2 Diabetes Within 2 Years After the First Drug-Eluting Stent Implantation.
首次药物洗脱支架植入术后2年内老年冠心病合并2型糖尿病患者支架内再狭窄相关危险因素的调查
Front Cardiovasc Med. 2022 May 20;9:837330. doi: 10.3389/fcvm.2022.837330. eCollection 2022.
4
The Mechanisms of Restenosis and Relevance to Next Generation Stent Design.再狭窄的机制与下一代支架设计的相关性。
Biomolecules. 2022 Mar 10;12(3):430. doi: 10.3390/biom12030430.
5
Pathogenesis and Clinical Significance of In-Stent Restenosis in Patients with Diabetes.糖尿病患者支架内再狭窄的发病机制及临床意义。
Int J Environ Res Public Health. 2021 Nov 15;18(22):11970. doi: 10.3390/ijerph182211970.
6
Is Coronary Brachytherapy Staging a Comeback for the Treatment of In-Stent Restenosis?冠状动脉内照射治疗术是否会重新成为支架内再狭窄的治疗手段？
Curr Cardiol Rep. 2021 Oct 1;23(11):156. doi: 10.1007/s11886-021-01582-4.
7
Efficacy and Biosafety of a New Bioresorbable Vascular Scaffold Covered with Biodegradable Film in Rabbits: An In Vivo Study.新型可生物降解薄膜覆盖可生物吸收血管支架在兔体内的有效性及生物安全性：一项体内研究
Acta Cardiol Sin. 2020 Nov;36(6):660-666. doi: 10.6515/ACS.202011_36(6).20200421B.
8
Mechanisms of drug-eluting stent restenosis.药物洗脱支架再狭窄的机制。
Cardiovasc Interv Ther. 2021 Jan;36(1):23-29. doi: 10.1007/s12928-020-00734-7. Epub 2020 Nov 21.
9
Drug-eluting stents: new presumed effects over in-stent restenosis prevention.药物洗脱支架：预防支架内再狭窄的新假定作用。
Minerva Cardiol Angiol. 2021 Apr;69(2):141-143. doi: 10.23736/S2724-5683.20.05372-4. Epub 2020 Sep 25.
10
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.糖尿病对药物洗脱支架再植入治疗支架内再狭窄后长期预后的影响。
BMC Cardiovasc Disord. 2017 Jan 6;17(1):16. doi: 10.1186/s12872-016-0445-6.